132 related articles for article (PubMed ID: 37774434)
1. Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a
Fu L; Huang J; Liu Q; Xie F; Han Y; Sun P; Cao M; Huang Y; Hu K; Tang G
Bioorg Chem; 2023 Dec; 141():106878. PubMed ID: 37774434
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
[TBL] [Abstract][Full Text] [Related]
3. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
4. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preclinical evaluation of novel
Zhou H; Zhong J; Peng S; Liu Y; Tang P; Cai Z; Wang L; Xu H; Hu K
Eur J Med Chem; 2024 Jan; 264():115993. PubMed ID: 38039792
[TBL] [Abstract][Full Text] [Related]
6. Preclinical study and first-in-human imaging of [
Liu L; Zhong J; Zhang Z; Ye X; Wang X; Liu S; Zhang Z
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2012-2022. PubMed ID: 38326656
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation and pilot clinical study of [
Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G
Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation and pilot clinical study of [
Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
[TBL] [Abstract][Full Text] [Related]
9.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Preliminary Study of
Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. [
Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
[TBL] [Abstract][Full Text] [Related]
14. Translational imaging of the fibroblast activation protein (FAP) using the new ligand [
Backhaus P; Gierse F; Burg MC; Büther F; Asmus I; Dorten P; Cufe J; Roll W; Neri D; Cazzamalli S; Millul J; Mock J; Galbiati A; Zana A; Schäfers KP; Hermann S; Weckesser M; Tio J; Wagner S; Breyholz HJ; Schäfers M
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1822-1832. PubMed ID: 34957527
[TBL] [Abstract][Full Text] [Related]
15.
Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
[TBL] [Abstract][Full Text] [Related]
16.
Li H; Ye S; Li Li ; Zhong J; Yan Q; Zhong Y; Feng P; Hu K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2705-2715. PubMed ID: 35290473
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
18. A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging.
Zhao X; Zhang G; Chen J; Li Z; Shi Y; Li G; Zhai C; Nie L
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1593-1604. PubMed ID: 38512485
[TBL] [Abstract][Full Text] [Related]
19. Clinical translational evaluation of Al
Wang S; Zhou X; Xu X; Ding J; Liu S; Hou X; Li N; Zhu H; Yang Z
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4259-4271. PubMed ID: 34165601
[TBL] [Abstract][Full Text] [Related]
20. Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [
Sun F; Wang C; Feng H; Yu F; Zhang X; Zhang P; Du X
Mol Pharm; 2023 May; 20(5):2634-2641. PubMed ID: 37043243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
